“Our current understanding of the pathophysiological basis of MacTel has led to the development of novel therapeutic approaches that may be able to break ground in this disease state.” Macular ...

This is used to check if the vessels affected by MacTel are leaking fluid into the retina. Finally, your healthcare provider will perform an optical coherence tomography, a newer, more advanced way of ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Compared with sham, patients implanted with NT-501 (revakinagene taroretcel, Neurotech Pharmaceuticals) for macular telangiectasia (MacTel) experienced less ellipsoid zone loss, a reduction in the ...

001). PDUFA date: March 18, 2025. Macular telangiectasia type 2 (MacTel) is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.

Feb. 21, 2025 — Researchers have developed a fully biobased hair conditioner using lignin gel emulsions, offering a sustainable and environmentally friendly alternative to conventional haircare ...